A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma: analysis by age

R. Kefford, E. Hersh, M. Del Vecchio, M. P. Brown, C. Loquai, A. Testori, C. Robert, M. Li, Elias, M. F. Renschler, A. Hauschild

Research output: Contribution to journalMeeting abstract

Cite this